HBio organized the 4th HBio Forum 2025 on 6-7th March 2025 at Megaron Athens Conference Hall
HBio once more organized the successful Hellenic Biocluster Forum.
It was a 2-day programme discussing all the emerging trends in Life Science Innovation. Stakeholders from the Greek and European innovation ecosystems had the chance to connect through physical and digital B2B partnering opportunities, meet exhibitors showcasing the latest technology, pitch to investors and connect to SMEs, policy makers, life sciences clusters, service providers, big pharma and academic institutions.
HBio participated in the "Innovation Greece 6.0: Innovation in Greece and the supporting stakeholders'' conference on January 29-30, 2025 at NCSR "DEMOKRITOS".
"Innovation Greece 6.0: Innovation in Greece and the supporting stakeholders'' took place in January 29 at NCSR Demokritos and it was about how the rapidly evolving Artificial Intelligence transforms the biosciences ecosystem, enhances faster drug development, and affects the pharmaceutical and healthcare sectors.
Dr. Ioanna Koukli, President of the HBio was there discussing about the revolutionary potential of Artificial Intelligence and how it reshapes the future of healthcare.
HBio participated in The ''Emerging Tech Forum'' on 11th December 2024 in Athens
HBio supports innovation by participating in The Emerging Tech Forum on 11th December 2024 in Athens, proposing strategies to leverage Greece's advancements in the global technology sector. Alexandros Triglimas, member of the HBio board, participated in the High-Tech Alliances panel, highlighting the crucial role Life Sciences have in shaping Greece’s global competitiveness. Thank you HETiA-Hellenic Emerging Technologies Industry Association for the invitation!
HBio was part of the 13th Clinical Research Conference held on December 3, 2024 in Athens!
HBio was part of the 13th Clinical Research Conference held on December 3, 2024 in Athens!
A full day of discussions on critical sector topics including clinical trials, healthcare research methodologies and public awareness raising in clinical research for disease prevention, diagnosis, and treatment. HBio continues to support Life Sciences innovation in Healthcare!
HBio participated in the "Merging Medicine, Law & IT for Humanity" conference on November 14-15, 2024
Dr. Ioanna Koukli, President of HBio participated in the "Merging Medicine, Law & IT for Humanity" conference on November 14-15, 2024 at the Stavros Niarchos Cultural Centre. The panel discussed about the developments in the Health Sector from the Medicine, Law and Informatics perspective and how the rapidly changing modern era affects the pharmaceutical and medical technology sectors.
HBio sponsored the Biennial International LRRK2 meeting of the Biochemical Society, organized by Anacalypsis Therapeutics in Crete.
18-21/06/2024: HBio proudly supported and sponsored the Biennial International LRRK2 meeting of the Biochemical Society, organized by Anacalypsis Therapeutics in Crete.
HBio supported the 8th Health Innovation Conference, organized by ethosEVENTS.
16/05/2024: HBio proudly supported the 8th Health Innovation Conference, organized by ethosEVENTS, focusing on how Health Innovation can be a catalyst for improving the National Health System. Dr. Ioanna Koukli, HBio president and CEO of PHARMASSIST discussed with the Minister of Health, Adonis Georgiadis the upcoming trends in healthcare.
HBio participated in the annual meeting of Council of European BioRegions in Paris.
14-15/05/2024: Stamatiki Krita as Managing Director of the Council of European BioRegions, participated in the annual meeting, co-organized and hosted by Genopole and Medicin Paris Region in Paris.
HBio is part of the MEDIC Nest Meta Cluster team!
07-08/05/2024: HBio participated as the only Biotech & Life Sciences cluster in Greece in the EU Cluster Conference in Brussels Conference in Brussels.
HBio participated in a Site visit to the Novartis Headquarters in Basel, Switzerland.
24/04: HBio participated in a Site visit to the Novartis Headquarters. We visited the Novartis campus in Basel, Switzerland.